Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China · Delayed Price · Currency is CNY 29.20
+0.69 (2.42%)
At close: Feb 3, 2026
25.92% (1Y)
| Market Cap | 2.95B +27.5% |
| Revenue (ttm) | 888.64M +14.6% |
| Net Income | 52.06M +47.1% |
| EPS | 0.52 +49.9% |
| Shares Out | 101.08M |
| PE Ratio | 56.02 |
| Forward PE | n/a |
| Dividend | 0.35 (1.20%) |
| Ex-Dividend Date | Jan 8, 2026 |
| Volume | 1,282,412 |
| Average Volume | 1,980,241 |
| Open | 28.80 |
| Previous Close | 28.51 |
| Day's Range | 28.38 - 29.23 |
| 52-Week Range | 21.64 - 39.66 |
| Beta | 0.58 |
| RSI | 54.71 |
| Earnings Date | Apr 27, 2026 |